accountMay 26 (Bloomberg) -- Abbott Laboratories��� Niaspan failed to prevent heart attacks and may have boosted stroke risk in a U.S.-funded study that calls into question the benefit of raising good cholesterol to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Cholesterol Combination Fails to Protect Heart in Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account